NCT06631820View on ClinicalTrials.gov

The Effect of the Nutraceutical (-)- Epicatechin on Myosteatosis in Patients With Advanced CKD

NARecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 17, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

October 31, 2026

Conditions
Chronic Kidney Disease(CKD)MyosteatosisMitochondrial DysfunctionMuscle FunctionMuscle Mass
Interventions
DIETARY_SUPPLEMENT

Epicatechin extract

In the experimental phase, patients will take 50 mg of (-)- Epicatechin twice a day for 8 weeks (total dose 100mg/day). The nutraceutical will be supplied as monodose sachets from Aayam Therapeutics.Study participants will mix the sachet powder with juice (10-20mL) in the morning 15 minutes before breakfast and in the evening 15 minutes before sleeping or 1h after dinner.

Trial Locations (1)

14152

RECRUITING

Karolinska University Hospital, Huddinge

All Listed Sponsors
lead

Karolinska Institutet

OTHER